Open AccessNovel reaction to new cystic fibrosis medication Trikafta
Author(s) -
Stashower Julian,
Carr Patrick,
Miller Virginia,
Zlotoff Barrett
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4116
Subject(s) - medicine , cystic fibrosis , ivacaftor , drug reaction , drug , intensive care medicine , pharmacology , cystic fibrosis transmembrane conductance regulator
We present a novel case of an urticaria multiforme‐type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms after beginning Trikafta.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom